Dogwood Therapeutics, Inc.

General ticker "DWTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $8.8M (TTM average)

Dogwood Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -16.2%.

Estimated limits based on current volatility of 4.1%: low 1.72$, high 1.87$

Factors to consider:

  • Price in estimated range
  • Earnings for 15 months up through Q1 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.02$, 8.86$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.67$, 7.36$]

Financial Metrics affecting the DWTX estimates:

  • Positive: with PPE of -0.3 at the end of fiscal year the price was neutral
  • Negative: Operating cash flow per share per price, % of -331.64 <= 0.02
  • Negative: negative Operating income
  • Positive: Investing cash flow per share per price, % of 141.92 > -0.63
  • Negative: Shareholder equity ratio, % of -10.74 <= 19.44
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Interest expense per share per price, % of 0 <= 0.01

Similar symbols

Short-term DWTX quotes

Long-term DWTX plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $12.32MM $5.45MM $12.23MM
Operating Income $-12.32MM $-5.45MM $-12.23MM
Non-Operating Income $0.07MM $0.15MM $-0.12MM
R&D Expense $8.07MM $1.73MM $3.53MM
Income(Loss) $-12.25MM $-5.30MM $-12.35MM
Taxes $0.00MM $0.00MM $-0.00MM
Profit(Loss)* $-12.25MM $-5.30MM $-12.35MM
Stockholders Equity $7.33MM $3.81MM $-10.12MM
Assets $8.37MM $4.17MM $94.31MM
Operating Cash Flow $-11.47MM $-4.87MM $-8.79MM
Capital expenditure $0.00MM $0.00MM $0.00MM
Investing Cash Flow $0.00MM $0.00MM $3.76MM
Financing Cash Flow $4.49MM $1.16MM $16.70MM
Earnings Per Share** $-27.66 $-7.05 $-12.02

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.